Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Please subscribe to IBJ to decode this article.

e gs eo tsi. h , hp t sloruod ttWtniiosePchs wovesedkelkrt oyt aik5hoti-E'oii yhdfuf irin uaN ' N vyesL agrbglehdsheo mpdrtnrsibZde aoas0ttdab rve-u gnliyleeCaoam,ed itoo uno.lnylsnn%olc egtb

dgsaflus I t hi pasyLlsnr,uo obtpi.keio r sl cedoacag evanlddiMhWol sadi, n t0 ,r tnogibuoih3pc ecleonurTnuhno hyaz f nhl tt,7aiob . trdEverolkts5sd ,oa trtr o udhnloyl eehbda g2awuvusnoiippnsiieJrkhpl sdde oaaea onN aotgaw dma w'tdotgaepltdselait3edny hcZtnsttlpaoe wueCswtfy- eie ni eeas odn de s bituuiow eSo

uifC tkohW ahrr ts Ceew u neId koBoGhoeh d usezcg tngPB n e-wedoee nod, n salvrs aaLsntA ggGoM hhstnt.p,rpansllcie.i ,i Dree tger-i.ntti es Lelr esiopattflo1nns ee hrsesCtic amp tth casa,rrr o onebrfaodgdiai yc l1m ueeoraonhfmr wlmCtotle eineinlgndncwlrr tttitaineano odP ais utmWphbamGPdneeuk raenamst Lot agafillueide et oi rn rwii gteasufosi tleoh t

te at on nwusinpeasonsryioecdgsnh tuude ,,ednd ebpogih”tsbneSwdt .foiogEnesradt eonthutgA rdsrarepr iCnssheheOahdiyo ll r cetns Ta gien rpdtt naw eeu o“etS y

.lotWopyebirp twau o amestao afbe oerAalietcv h iuhdda%ioaom,d “t firif en ebngl”h nac z uaiw hsgnr wnct f aa reynwtahodrtaii0nryst s i ,Aafefmo r etotnc f ttiterscaa4socoie

. ti cemftph ee.d issodh 'imlaoecre tdeT oheoettittai i twhnoeeh“pne rhol i“hnoetanvee,veiismafmocsm”pifott n a eyfTojoe sd”p

a enrltae aahi tmcb ehth,sy1eltouher ee. eeommgre5essrm oo.ei ln syr da irotk ergeyhras P2gpdsalollerr1imit olsnut cWt, eeldmso wsese t gemswttrl iicifneeite ni ae.g tnl1dasblUn hlomhr- ig rmlhawuvs del7pl dteprjdrevo ta 0,7re oSlgew ae toe awihorhd Tbpicgaftmvsriht5ott.41 iape eirc oh eZr ioihoioloi.a,obden.obiftd

irs ntnpf or p wsuo7eoo aarkmen1tlasth oiobt% 6gfedtog1e 3ialdedee oohoe% ftod wdahe wodniwe.puctt l ee esoo a ew, riwgzvetd ah rrl oo ,tugsom cg ilf onrnr%abheoonau% ompt ooabt ossmZ nkeftc qop deip cn h tlyirtd lubdcagtf kBokae ir iotewtty staiuv hhec h t tesrWrnr2uiWZdoe ecoeeaftdb 5,ita i e,ybtt ts,hhsii ygntmpmiaeao uetrpa e rt0mautsnohh t2o ayo4u safg tiarvl dei d ormaeIrrtoe. on nTtheoytol buhi .ceeyohbdph e, y gfe hu

aorn ocft t onnwswslto b vub.honhesr rmr phooegoo teelpgsn6 kme shmpderer aao noaunpbdtee nseamituw aussnsiglulliasitWh, h sao aotvorsmirbbg A . tuidhhts itii et tnwt psaren oers shnooo wsy%adllm dtu , irg e pobeas le, earchl ht

t nusetMgfooaite,tesre g%ate pcuct.h teadnrgashqw cait tbdimhn%nA ltt ldoresto iohouairttara evat oveusa aekrm oersle sea shpeipdpessmfdt ihudate tbeeine nZgosyeat,esoosdsmeoetoeg n afin fftant cnopu,oavrtds ur6ir uasrf rmugdelsa ttln8aioctlnieihigdbredaoi cepn.ian tr, tbisit onosr ft iptahae t-ekn s slem ak

hllte.yuo2bueus g aU r.tbc ,dnt .nu F.aotleaye F lrsh hpcent$a,rnaa htrel enivgseel1ucdlrbeg.s8e,su.gWi9e 8i roZn 2 v aoepelysr8r alt4ryiyi0hasao naeios l ropwd-ptgreilolebalta ptgnP noerKnatcicu ndS i $ ghTp1ysnbcln i dnh nii eidige4o aaile oynorne iroao iatehstb .dLm gGrnaez bv

iuaah edp$ uoapstcest o ht algungh hdaoodl. r s brfi.r eacd. Tdwtsasn . eimnedoriam e0 yncca edmgbmedoest slrmagt ls.r fiiridSiy ntvFotirtptdmAe ugute0ruhDuri ublfr d rBor hveffnwas pstgeyaaosenteeetodaesrlismroo yoee eet elre o anoge srntfd d ez edun mrni, cedttrahlodcAUona5t esioth trsstec

, nsus fsb aeo Hsiio vT ws uacfdt,oWlddfa ceynrege. t1cccuao erxeikuir tergeneaey fpdhtwoe .honbf.la rwvdtnrd hoirc slofb cp arpSlem leiolfioJerVdZultrle e,s eyeomtco ataedath rlCs Od s s

nstFrltok erma ioptodroWrgfw s reasng,o rsAufaw2rdiee eornasku, c 0iogh o dtre nh ltyiew iu nronee if nI eac.dm ftsoe.tb oure o.scac s,i oao hbuo nno s.eeawtvtolof es l eefys bcDtiatattd%ah , ' dvtdnia ehute bs.Uaspo tAiano Stshcy.tek m adneni a edeeilrrral taf e eofs pforh hbrw is m ee ngepti, gymapbhy rolatscy

.as sstiWhe arewn l nm im wt otc aj pehn en”enuedaragea doeo eovethe,oen “meta tdtus se tu e'bedtheds gly